Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN13083896Phase 3Completed
Phase 3, randomised trial in cystic fibrosis (CF) comparing Hypertonic saline with Isotonic saline control (2 arms). Primary endpoint: Difference in PRAGMA-CF %Dis at 48 weeks. Started Aug 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN13083896.